Modification of the pharmacokinetics of MVE-2 to enhance its effects on host resistance.
D000818:Animals; D001424:Bacterial Infections / Q000188:drug therapy; D007109:Immunity / Q000187:drug effects*; D007275:Injections, Intravenous; D007694:Killer Cells, Natural / Q000187:drug effects; D008168:Lung / Q000187:drug effects; D008264:Macrophages / Q000187:drug effects; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011108:Polymers / Q000494:pharmacology*; D011713:Pyran Copolymer / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*
D011108:Polymers; D011713:Pyran Copolymer